• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 2.19% 67.0¢

RECCE PHARMACEUTICALS LTD - Announcements

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE UPDATE HIGHLIGHTS KEY DEVELOPMENTS FOR UPSIDE

Announcements


RCE Safety Committee Approves High Dose of 4,000mgPRICE SENSITIVE26/04/24 download Created with Sketch. 263.52KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE22/04/24 download Created with Sketch. 575.83KB
RCE Cleansing Statement16/04/24 download Created with Sketch. 193.34KB
RCE Application for quotation of securities - RCE16/04/24 download Created with Sketch. 16.67KB
RCE Recce Completes 5,000 R327 Doses Per Week under GMPPRICE SENSITIVE16/04/24 download Created with Sketch. 217.27KB
RCE Recce Pharmaceuticals - Business UpdatePRICE SENSITIVE08/04/24 download Created with Sketch. 582.67KB
RCE Patent Granted in Israel for RECCE Anti-InfectivesPRICE SENSITIVE03/04/24 download Created with Sketch. 324.65KB
RCE RECCE Trademark Registered - Canada21/03/24 download Created with Sketch. 216.83KB
RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical TrialPRICE SENSITIVE15/03/24 download Created with Sketch. 278.98KB
RCE Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical TrialPRICE SENSITIVE12/03/24 download Created with Sketch. 262.97KB
RCE Recce Receives AUD $11.17m R&D AdvancePRICE SENSITIVE08/03/24 download Created with Sketch. 238.07KB
RCE Appendix 4D and Interim Financial ReportPRICE SENSITIVE27/02/24 download Created with Sketch. 464.55KB
RCE Notification of cessation of securities - RCE27/02/24 download Created with Sketch. 12.78KB
RCE Recce Continues Strategic Partnership with MCRI27/02/24 download Created with Sketch. 274.91KB
RCE Safety Committee Approves Expansion of Ph I/II DFI TrialPRICE SENSITIVE26/02/24 download Created with Sketch. 246.18KB
RCE MoU Clarification Announcement13/02/24 download Created with Sketch. 170.43KB
RCE RCE Establishes Strategic Partnership in South-East AsiaPRICE SENSITIVE06/02/24 download Created with Sketch. 451.89KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/24 download Created with Sketch. 746.24KB
RCE Positive Ph I/II DFI Efficacy Data to Support Site ExpansionPRICE SENSITIVE18/01/24 download Created with Sketch. 266.33KB
RCE Murdoch Children's R327 Efficacy UTI in-vivoPRICE SENSITIVE28/12/23 download Created with Sketch. 384.21KB
RCE RCE Awarded Further $11.17m Advanced Overseas FindingPRICE SENSITIVE15/12/23 download Created with Sketch. 382.33KB
RCE Change of Director's Interest Notices14/12/23 download Created with Sketch. 908.39KB
RCE RCE Awarded $43.7m AusIndustry Advanced Overseas FindingPRICE SENSITIVE14/12/23 download Created with Sketch. 376.84KB
RCE Murdoch Children's R327 Efficacy N.gonorrhoeae in-vivoPRICE SENSITIVE14/12/23 download Created with Sketch. 375.27KB
RCE Application for quotation of securities - RCE07/12/23 download Created with Sketch. 24.72KB
RCE Canadian Patent Granted for RECCE Anti-InfectivesPRICE SENSITIVE23/11/23 download Created with Sketch. 320.09KB
RCE Notification of cessation of securities - RCE17/11/23 download Created with Sketch. 21.58KB
RCE Results of Meeting08/11/23 download Created with Sketch. 151.49KB
RCE AGM Presentation08/11/23 download Created with Sketch. 1.5MB
RCE Subjects Dosed Over 15 mins in UTI/Urosepsis Clinical TrialPRICE SENSITIVE07/11/23 download Created with Sketch. 230.98KB
RCE RCE Corporate Presentation at Ord Minnett Healthcare Forum31/10/23 download Created with Sketch. 7.36MB
RCE Committee Approves Fast 15-Min Infusion in Ph I/II UrosepsisPRICE SENSITIVE24/10/23 download Created with Sketch. 305.03KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE20/10/23 download Created with Sketch. 1.02MB
RCE Application for quotation of securities - RCE13/10/23 download Created with Sketch. 24.98KB
RCE Correction to Notice of Annual General Meeting13/10/23 download Created with Sketch. 468.03KB
RCE Notice of Annual General Meeting/Proxy Form09/10/23 download Created with Sketch. 794.37KB
RCE Change of Director's Interest Notices06/10/23 download Created with Sketch. 690.74KB
RCE Correction to ASX Announcement05/10/23 download Created with Sketch. 133.02KB
RCE Placement of Entitlement Offer Shortfall05/10/23 download Created with Sketch. 219.83KB
RCE Appendix 4G29/09/23 download Created with Sketch. 264.71KB
RCE Annual Report to Shareholders29/09/23 download Created with Sketch. 5.86MB
RCE Entitlement Offer - Announcement of Results29/09/23 download Created with Sketch. 212.92KB
RCE Application for quotation of securities - RCE29/09/23 download Created with Sketch. 24.94KB
RCE Completes Cohort Dosing UTI/Urosepsis Rapid Infusion TrialPRICE SENSITIVE22/09/23 download Created with Sketch. 268.92KB
RCE Becoming a substantial holder20/09/23 download Created with Sketch. 666.06KB
RCE 2023 Annual General Meeting18/09/23 download Created with Sketch. 148KB
RCE Cleansing Statement18/09/23 download Created with Sketch. 267.24KB
RCE Application for quotation of securities - RCE18/09/23 download Created with Sketch. 24.99KB
RCE Entitlement Offer - Notification to Ineligible Shareholders15/09/23 download Created with Sketch. 155.49KB
RCE Entitlement Offer Booklet15/09/23 download Created with Sketch. 755.49KB
RCE Cleansing Statement11/09/23 download Created with Sketch. 264.35KB
RCE Application for quotation of securities - RCE11/09/23 download Created with Sketch. 24.81KB
RCE Cleansing Notice - Entitlement Offer11/09/23 download Created with Sketch. 411.06KB
RCE Proposed issue of securities - RCE11/09/23 download Created with Sketch. 36.03KB
RCE Placement and Entitlement OfferPRICE SENSITIVE11/09/23 download Created with Sketch. 276.98KB
RCE Trading HaltPRICE SENSITIVE08/09/23 download Created with Sketch. 317.42KB
RCE Opening R&D Address at World AMR CongressPRICE SENSITIVE08/09/23 download Created with Sketch. 3.23MB
RCE RECCE Trademark Registered - VietnamPRICE SENSITIVE06/09/23 download Created with Sketch. 289.61KB
RCE Additional Positive Patient Cases - Special Access SchemePRICE SENSITIVE31/08/23 download Created with Sketch. 497.11KB
RCE Appendix 4E and Unaudited Preliminary ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 503.53KB
RCE Next Dose Cleared in Rapid Infusion Phase I/II UTI TrialPRICE SENSITIVE28/08/23 download Created with Sketch. 256.66KB
RCE Patients Dosed in R327 Diabetic Foot Infection TrialPRICE SENSITIVE22/08/23 download Created with Sketch. 281.98KB
RCE Phase I/II Burn Wound Infection Trial Stage 1 CompletePRICE SENSITIVE21/08/23 download Created with Sketch. 349.53KB
RCE Positive Patients Update - Special Access SchemePRICE SENSITIVE08/08/23 download Created with Sketch. 537.59KB
RCE Australian Patent Granted for RECCE Anti-InfectivesPRICE SENSITIVE03/08/23 download Created with Sketch. 318.83KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 480.05KB
RCE Bonus Canadian R&D Rebate ReceivedPRICE SENSITIVE28/07/23 download Created with Sketch. 265.44KB
RCE Scientia Completes Cohort Dosing in Phase I/II UTI TrialPRICE SENSITIVE28/07/23 download Created with Sketch. 273.47KB
RCE Abstract & Poster Presentation at US Military Symposium27/07/23 download Created with Sketch. 304.57KB
RCE Scientia Doses Ahead of Schedule in Phase I/II UTI TrialPRICE SENSITIVE24/07/23 download Created with Sketch. 273.72KB
RCE Clarification - 5x Higher Concentration in Urine & PlasmaPRICE SENSITIVE20/07/23 download Created with Sketch. 168.73KB
RCE Phase I Clinical Trial Data Review CompletePRICE SENSITIVE19/07/23 download Created with Sketch. 631.65KB
RCE A$801,604 R&D Rebate Advance ReceivedPRICE SENSITIVE12/07/23 download Created with Sketch. 223.17KB
RCE First Cohort Dosed in Rapid Infusion Phase I/II UTI studyPRICE SENSITIVE10/07/23 download Created with Sketch. 266.1KB
RCE Ethics Approval for Phase I/II UTI Trial ExpansionPRICE SENSITIVE29/06/23 download Created with Sketch. 280.54KB
RCE Change of Director's Interest Notice - J Graham26/06/23 download Created with Sketch. 353.29KB
RCE DFI Clinical Trial Outpatient Nurses Appointed29/05/23 download Created with Sketch. 272.88KB
RCE WA Government Sponsorship for BIO Korea 202308/05/23 download Created with Sketch. 310.63KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 710.13KB
RCE Ethics Approval to Start Phase I/II (I.V.) Clinical TrialPRICE SENSITIVE17/04/23 download Created with Sketch. 258.68KB
RCE RECCE Trademark Registered - Israel12/04/23 download Created with Sketch. 263.79KB
RCE New Family 4 Patent to be Granted for RECCE Anti-InfectivesPRICE SENSITIVE11/04/23 download Created with Sketch. 272.7KB
RCE Recce Receives Further A$973,144 R&D AdvancePRICE SENSITIVE04/04/23 download Created with Sketch. 220.97KB
RCE Corporate Presentation - WI Emergence 2023PRICE SENSITIVE23/03/23 download Created with Sketch. 2.82MB
RCE Appendix 4D and Interim Financial ReportPRICE SENSITIVE27/02/23 download Created with Sketch. 312KB
RCE Investor Presentation - Spark Plus Biotech Day24/02/23 download Created with Sketch. 4.01MB
RCE Recce Selects CMAX for Phase I/II UTI Clinical TrialPRICE SENSITIVE20/02/23 download Created with Sketch. 393.65KB
RCE Cleansing Statement14/02/23 download Created with Sketch. 158.39KB
RCE Application for quotation of securities - RCE14/02/23 download Created with Sketch. 24.79KB
RCE RECCE Trademark Registered - Hong Kong02/02/23 download Created with Sketch. 234.19KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/23 download Created with Sketch. 613.04KB
RCE A$6.21m Received from R&D Rebate PaymentsPRICE SENSITIVE25/01/23 download Created with Sketch. 317.75KB
RCE Cleansing Statement11/01/23 download Created with Sketch. 159.46KB
RCE Application for quotation of securities - RCE11/01/23 download Created with Sketch. 24.79KB
RCE JP Morgan Healthcare ConferencePRICE SENSITIVE10/01/23 download Created with Sketch. 3.42MB
RCE Australian Patent to be Granted for RECCE Anti-InfectivesPRICE SENSITIVE10/01/23 download Created with Sketch. 250.74KB
RCE Anti-Infective Research Unit est. at Murdoch Children'sPRICE SENSITIVE15/12/22 download Created with Sketch. 319.96KB
RCE Approval to Start Phase I/II Diabetic Foot Ulcer StudyPRICE SENSITIVE09/12/22 download Created with Sketch. 329.13KB
RCE Trading HaltPRICE SENSITIVE07/12/22 download Created with Sketch. 643.19KB
RCE Pause in TradingPRICE SENSITIVE07/12/22 download Created with Sketch. 113.49KB
RCE Safety Committee Approves High Dose of 4,000mg
26/04/24PRICE SENSITIVE download Created with Sketch. 263.52KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
22/04/24PRICE SENSITIVE download Created with Sketch. 575.83KB
RCE Cleansing Statement
16/04/24 download Created with Sketch. 193.34KB
RCE Application for quotation of securities - RCE
16/04/24 download Created with Sketch. 16.67KB
RCE Recce Completes 5,000 R327 Doses Per Week under GMP
16/04/24PRICE SENSITIVE download Created with Sketch. 217.27KB
RCE Recce Pharmaceuticals - Business Update
08/04/24PRICE SENSITIVE download Created with Sketch. 582.67KB
RCE Patent Granted in Israel for RECCE Anti-Infectives
03/04/24PRICE SENSITIVE download Created with Sketch. 324.65KB
RCE RECCE Trademark Registered - Canada
21/03/24 download Created with Sketch. 216.83KB
RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
15/03/24PRICE SENSITIVE download Created with Sketch. 278.98KB
RCE Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
12/03/24PRICE SENSITIVE download Created with Sketch. 262.97KB
RCE Recce Receives AUD $11.17m R&D Advance
08/03/24PRICE SENSITIVE download Created with Sketch. 238.07KB
RCE Appendix 4D and Interim Financial Report
27/02/24PRICE SENSITIVE download Created with Sketch. 464.55KB
RCE Notification of cessation of securities - RCE
27/02/24 download Created with Sketch. 12.78KB
RCE Recce Continues Strategic Partnership with MCRI
27/02/24 download Created with Sketch. 274.91KB
RCE Safety Committee Approves Expansion of Ph I/II DFI Trial
26/02/24PRICE SENSITIVE download Created with Sketch. 246.18KB
RCE MoU Clarification Announcement
13/02/24 download Created with Sketch. 170.43KB
RCE RCE Establishes Strategic Partnership in South-East Asia
06/02/24PRICE SENSITIVE download Created with Sketch. 451.89KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24PRICE SENSITIVE download Created with Sketch. 746.24KB
RCE Positive Ph I/II DFI Efficacy Data to Support Site Expansion
18/01/24PRICE SENSITIVE download Created with Sketch. 266.33KB
RCE Murdoch Children's R327 Efficacy UTI in-vivo
28/12/23PRICE SENSITIVE download Created with Sketch. 384.21KB
RCE RCE Awarded Further $11.17m Advanced Overseas Finding
15/12/23PRICE SENSITIVE download Created with Sketch. 382.33KB
RCE Change of Director's Interest Notices
14/12/23 download Created with Sketch. 908.39KB
RCE RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
14/12/23PRICE SENSITIVE download Created with Sketch. 376.84KB
RCE Murdoch Children's R327 Efficacy N.gonorrhoeae in-vivo
14/12/23PRICE SENSITIVE download Created with Sketch. 375.27KB
RCE Application for quotation of securities - RCE
07/12/23 download Created with Sketch. 24.72KB
RCE Canadian Patent Granted for RECCE Anti-Infectives
23/11/23PRICE SENSITIVE download Created with Sketch. 320.09KB
RCE Notification of cessation of securities - RCE
17/11/23 download Created with Sketch. 21.58KB
RCE Results of Meeting
08/11/23 download Created with Sketch. 151.49KB
RCE AGM Presentation
08/11/23 download Created with Sketch. 1.5MB
RCE Subjects Dosed Over 15 mins in UTI/Urosepsis Clinical Trial
07/11/23PRICE SENSITIVE download Created with Sketch. 230.98KB
RCE RCE Corporate Presentation at Ord Minnett Healthcare Forum
31/10/23 download Created with Sketch. 7.36MB
RCE Committee Approves Fast 15-Min Infusion in Ph I/II Urosepsis
24/10/23PRICE SENSITIVE download Created with Sketch. 305.03KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
20/10/23PRICE SENSITIVE download Created with Sketch. 1.02MB
RCE Application for quotation of securities - RCE
13/10/23 download Created with Sketch. 24.98KB
RCE Correction to Notice of Annual General Meeting
13/10/23 download Created with Sketch. 468.03KB
RCE Notice of Annual General Meeting/Proxy Form
09/10/23 download Created with Sketch. 794.37KB
RCE Change of Director's Interest Notices
06/10/23 download Created with Sketch. 690.74KB
RCE Correction to ASX Announcement
05/10/23 download Created with Sketch. 133.02KB
RCE Placement of Entitlement Offer Shortfall
05/10/23 download Created with Sketch. 219.83KB
RCE Appendix 4G
29/09/23 download Created with Sketch. 264.71KB
RCE Annual Report to Shareholders
29/09/23 download Created with Sketch. 5.86MB
RCE Entitlement Offer - Announcement of Results
29/09/23 download Created with Sketch. 212.92KB
RCE Application for quotation of securities - RCE
29/09/23 download Created with Sketch. 24.94KB
RCE Completes Cohort Dosing UTI/Urosepsis Rapid Infusion Trial
22/09/23PRICE SENSITIVE download Created with Sketch. 268.92KB
RCE Becoming a substantial holder
20/09/23 download Created with Sketch. 666.06KB
RCE 2023 Annual General Meeting
18/09/23 download Created with Sketch. 148KB
RCE Cleansing Statement
18/09/23 download Created with Sketch. 267.24KB
RCE Application for quotation of securities - RCE
18/09/23 download Created with Sketch. 24.99KB
RCE Entitlement Offer - Notification to Ineligible Shareholders
15/09/23 download Created with Sketch. 155.49KB
RCE Entitlement Offer Booklet
15/09/23 download Created with Sketch. 755.49KB
RCE Cleansing Statement
11/09/23 download Created with Sketch. 264.35KB
RCE Application for quotation of securities - RCE
11/09/23 download Created with Sketch. 24.81KB
RCE Cleansing Notice - Entitlement Offer
11/09/23 download Created with Sketch. 411.06KB
RCE Proposed issue of securities - RCE
11/09/23 download Created with Sketch. 36.03KB
RCE Placement and Entitlement Offer
11/09/23PRICE SENSITIVE download Created with Sketch. 276.98KB
RCE Trading Halt
08/09/23PRICE SENSITIVE download Created with Sketch. 317.42KB
RCE Opening R&D Address at World AMR Congress
08/09/23PRICE SENSITIVE download Created with Sketch. 3.23MB
RCE RECCE Trademark Registered - Vietnam
06/09/23PRICE SENSITIVE download Created with Sketch. 289.61KB
RCE Additional Positive Patient Cases - Special Access Scheme
31/08/23PRICE SENSITIVE download Created with Sketch. 497.11KB
RCE Appendix 4E and Unaudited Preliminary Report
31/08/23PRICE SENSITIVE download Created with Sketch. 503.53KB
RCE Next Dose Cleared in Rapid Infusion Phase I/II UTI Trial
28/08/23PRICE SENSITIVE download Created with Sketch. 256.66KB
RCE Patients Dosed in R327 Diabetic Foot Infection Trial
22/08/23PRICE SENSITIVE download Created with Sketch. 281.98KB
RCE Phase I/II Burn Wound Infection Trial Stage 1 Complete
21/08/23PRICE SENSITIVE download Created with Sketch. 349.53KB
RCE Positive Patients Update - Special Access Scheme
08/08/23PRICE SENSITIVE download Created with Sketch. 537.59KB
RCE Australian Patent Granted for RECCE Anti-Infectives
03/08/23PRICE SENSITIVE download Created with Sketch. 318.83KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 480.05KB
RCE Bonus Canadian R&D Rebate Received
28/07/23PRICE SENSITIVE download Created with Sketch. 265.44KB
RCE Scientia Completes Cohort Dosing in Phase I/II UTI Trial
28/07/23PRICE SENSITIVE download Created with Sketch. 273.47KB
RCE Abstract & Poster Presentation at US Military Symposium
27/07/23 download Created with Sketch. 304.57KB
RCE Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
24/07/23PRICE SENSITIVE download Created with Sketch. 273.72KB
RCE Clarification - 5x Higher Concentration in Urine & Plasma
20/07/23PRICE SENSITIVE download Created with Sketch. 168.73KB
RCE Phase I Clinical Trial Data Review Complete
19/07/23PRICE SENSITIVE download Created with Sketch. 631.65KB
RCE A$801,604 R&D Rebate Advance Received
12/07/23PRICE SENSITIVE download Created with Sketch. 223.17KB
RCE First Cohort Dosed in Rapid Infusion Phase I/II UTI study
10/07/23PRICE SENSITIVE download Created with Sketch. 266.1KB
RCE Ethics Approval for Phase I/II UTI Trial Expansion
29/06/23PRICE SENSITIVE download Created with Sketch. 280.54KB
RCE Change of Director's Interest Notice - J Graham
26/06/23 download Created with Sketch. 353.29KB
RCE DFI Clinical Trial Outpatient Nurses Appointed
29/05/23 download Created with Sketch. 272.88KB
RCE WA Government Sponsorship for BIO Korea 2023
08/05/23 download Created with Sketch. 310.63KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 710.13KB
RCE Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
17/04/23PRICE SENSITIVE download Created with Sketch. 258.68KB
RCE RECCE Trademark Registered - Israel
12/04/23 download Created with Sketch. 263.79KB
RCE New Family 4 Patent to be Granted for RECCE Anti-Infectives
11/04/23PRICE SENSITIVE download Created with Sketch. 272.7KB
RCE Recce Receives Further A$973,144 R&D Advance
04/04/23PRICE SENSITIVE download Created with Sketch. 220.97KB
RCE Corporate Presentation - WI Emergence 2023
23/03/23PRICE SENSITIVE download Created with Sketch. 2.82MB
RCE Appendix 4D and Interim Financial Report
27/02/23PRICE SENSITIVE download Created with Sketch. 312KB
RCE Investor Presentation - Spark Plus Biotech Day
24/02/23 download Created with Sketch. 4.01MB
RCE Recce Selects CMAX for Phase I/II UTI Clinical Trial
20/02/23PRICE SENSITIVE download Created with Sketch. 393.65KB
RCE Cleansing Statement
14/02/23 download Created with Sketch. 158.39KB
RCE Application for quotation of securities - RCE
14/02/23 download Created with Sketch. 24.79KB
RCE RECCE Trademark Registered - Hong Kong
02/02/23 download Created with Sketch. 234.19KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23PRICE SENSITIVE download Created with Sketch. 613.04KB
RCE A$6.21m Received from R&D Rebate Payments
25/01/23PRICE SENSITIVE download Created with Sketch. 317.75KB
RCE Cleansing Statement
11/01/23 download Created with Sketch. 159.46KB
RCE Application for quotation of securities - RCE
11/01/23 download Created with Sketch. 24.79KB
RCE JP Morgan Healthcare Conference
10/01/23PRICE SENSITIVE download Created with Sketch. 3.42MB
RCE Australian Patent to be Granted for RECCE Anti-Infectives
10/01/23PRICE SENSITIVE download Created with Sketch. 250.74KB
RCE Anti-Infective Research Unit est. at Murdoch Children's
15/12/22PRICE SENSITIVE download Created with Sketch. 319.96KB
RCE Approval to Start Phase I/II Diabetic Foot Ulcer Study
09/12/22PRICE SENSITIVE download Created with Sketch. 329.13KB
RCE Trading Halt
07/12/22PRICE SENSITIVE download Created with Sketch. 643.19KB
RCE Pause in Trading
07/12/22PRICE SENSITIVE download Created with Sketch. 113.49KB
(20min delay)
Last
67.0¢
Change
-0.015(2.19%)
Mkt cap ! $136.6M
Open High Low Value Volume
69.0¢ 69.5¢ 66.0¢ $92.15K 136.3K

Buyers (Bids)

No. Vol. Price($)
1 5000 65.0¢
 

Sellers (Offers)

Price($) Vol. No.
68.0¢ 20752 2
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
66.0¢
  Change
-0.015 ( 1.54 %)
Open High Low Volume
68.5¢ 69.0¢ 66.0¢ 37117
Last updated 15.47pm 26/04/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.